APA (7th ed.) Citation

Q, P., L, X., X, H., Z, H., G, Z., J, Z., & Y, T. (2026). Berbamine sensitizes hepatocellular carcinoma to chemotherapy by inhibiting autophagy via modulating SIRT1-mediated acetylation. Frontiers in pharmacology, 17, 1763828. https://doi.org/10.3389/fphar.2026.1763828

Chicago Style (17th ed.) Citation

Q, Peng, Xiao L, Huang X, Huang Z, Zhang G, Zhou J, and Tan Y. "Berbamine Sensitizes Hepatocellular Carcinoma to Chemotherapy by Inhibiting Autophagy via Modulating SIRT1-mediated Acetylation." Frontiers in Pharmacology 17 (2026): 1763828. https://doi.org/10.3389/fphar.2026.1763828.

MLA (9th ed.) Citation

Q, Peng, et al. "Berbamine Sensitizes Hepatocellular Carcinoma to Chemotherapy by Inhibiting Autophagy via Modulating SIRT1-mediated Acetylation." Frontiers in Pharmacology, vol. 17, 2026, p. 1763828, https://doi.org/10.3389/fphar.2026.1763828.